Long-term results show gene therapy could help those with macular degeneration
Thursday 04 August 2016A pioneering treatment is giving new hope to those with macular degeneration. A team at Oxford University have successfully used gene therapy over the long-term to reverse sight loss in a group of patients in the UK and US who otherwise would have gone blind.
By injecting a working copy of the gene into the back of the eye, the researchers found that they not only halted choroideremia, but also revived some of the dying cells and improved the patients’ vision (in some instances, dramatically).
According to Professor Robert Maclaren, the eye surgeon leading the trial, “we seem to have achieved the concept of one single treatment that does not need to repeated which is unlike other medicines” Prof Maclaren has already started to develop gene therapy trials to treat more common forms of blindness including macular degeneration. These trials could begin as early as 2017.
Sources:
BBC News:
Gene therapy reverses sight loss and is long-lasting.University of Oxford News:
Gene therapy shows long-term benefit for treating rare blindness.
Comments
Post a comment…
A Serious Blog
News and views from around the world on lighting, eyecare and eye conditions.
Twitter: @seriousreaders
Facebook:facebook.com/seriousreaders
Recent posts
- Living with Glaucoma: National Eye Health Week
- The role of light in painting the sky blue
- Five essential summer eye care tips: How to take care of your eyes this summer
- The history of lighting at Wimbledon: A tale of illumination, innovation, and tradition
- From the Chelsea Flower Show to your home: The power of light in plant growth
Don't miss out on exclusive content and all the latest in light and sight. Subscribe to our email list now!